Sol-Gel Technologies (SLGL) Metrics: History & Chart

Sol-Gel Technologies Ltd.(SLGL)

Biotechnology · Ness Ziona, TA

$75.64-3.31 (-4.19%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates. Twyneo, an innovative, non-antibiotic topical cream designed for once-daily application, has successfully concluded Phase III trials for treating acne vulgaris. Similarly, Epsolay, another topical cream administered once a day, has also completed its Phase III studies, targeting papulopustular rosacea. Advancing through Phase I clinical trials is SGT-210, intended for palmoplantar keratoderma. Furthermore, the company is investigating Erlotinib, Tapinarof, and Roflumilast as potential treatments for psoriasis and various other medical conditions. Beyond its proprietary offerings, the company also engages in creating generic versions of topical dermatological medications. Sol-Gel Technologies maintains a strategic partnership with Perrigo. Established in 1997, the company maintains its headquarters in Ness Ziona, Israel.

Ness Ziona, TA

28 employees

www.sol-gel.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Moshe Arkin

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+13.68%
30D Total Return	+13.56%
YTD Total Return	+87.35%
1Y Total Return	+126.87%
3Y Total Return	+507.30%
5Y Total Return	-19.26%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+87.35%
2025	+353.12%
2024	-16.22%
2023	-75.66%
2022	-38.38%
2021	-24.41%
2020

CAGR TTM	+125.98%
CAGR 3Y	+82.42%
CAGR 5Y	-4.19%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	115.82
PE Ratio Avg TTM	48.03
PE Ratio Avg 3Y	40.56
Current VS TTM Avg	+141.15%
Current VS 3Y Avg	+185.55%
Current VS 5Y Avg	-5.84%

All Metrics

SLGL Valuation Metrics

SLGL Stock Price Metrics

SLGL Dividend Metrics

SLGL Growth Rate Metrics

SLGL Discounted Cash Flow Metrics

SLGL Returns By Period

SLGL Yearly Returns

SLGL Average Annual Returns By Period (CAGR)

SLGL Revenue Metrics

SLGL PE Ratio Metrics

SLGL PS Ratio Metrics

SLGL PB Ratio Metrics

SLGL Price to Free Cash Flow Ratio Metrics

SLGL Debt to Equity Ratio Metrics

SLGL PEG Ratio Metrics

SLGL FCF Yield

SLGL Earnings Yield

SLGL EBITDA Yield

SLGL OCF Yield

SLGL EV/EBIT Ratio Metrics

SLGL EV/EBITDA Ratio Metrics

SLGL EV/Assets Ratio Metrics

SLGL EV/Sales Ratio Metrics

SLGL Current Ratio Metrics

SLGL Quick Ratio Metrics

SLGL ROIC Metrics

SLGL Return on Assets Metrics

SLGL Return on Equity Metrics

SLGL Net Profit Margin Metrics

SLGL Gross Profit Margin Metrics

SLGL Tax Rate Metrics

PS Ratio	143.85
PS Ratio Avg TTM	9.59
PS Ratio Avg 3Y	12.15
Current VS TTM Avg	+1400.44%
Current VS 3Y Avg	+1084.38%
Current VS 5Y Avg	+105.39%

PB Ratio	5.37
PB Ratio Avg TTM	5.91
PB Ratio Avg 3Y	5.51
Current VS TTM Avg	-9.16%
Current VS 3Y Avg	-2.50%
Current VS 5Y Avg	-60.95%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.02
Debt/Equity Ratio Avg TTM	0.03
Debt/Equity Ratio Avg 3Y	0.04
Current VS TTM Avg	-48.32%
Current VS 3Y Avg	-61.42%
Current VS 5Y Avg	-50.53%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	0.86%
Earnings Yield Avg TTM	2.36%
Earnings Yield Avg 3Y	2.36%
Current VS TTM Avg	-63.62%
Current VS 3Y Avg	-63.51%
Current VS 5Y Avg	-37.26%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	63.18
Ev/Ebit Ratio Avg TTM	73.04
Ev/Ebit Ratio Avg 3Y	167.85
Current VS TTM Avg	-13.49%
Current VS 3Y Avg	-62.36%
Current VS 5Y Avg	-50.43%

Ev/Ebitda Ratio	52.58
Ev/Ebitda Ratio Avg TTM	60.78
Ev/Ebitda Ratio Avg 3Y	150.05
Current VS TTM Avg	-13.50%
Current VS 3Y Avg	-64.96%
Current VS 5Y Avg	-53.12%

Ev/Assets Ratio	4.51
Ev/Assets Ratio Avg TTM	4.46
Ev/Assets Ratio Avg 3Y	4.19
Current VS TTM Avg	+1.06%
Current VS 3Y Avg	+7.61%
Current VS 5Y Avg	-62.76%

Ev/Sales Ratio	135.00
Ev/Sales Ratio Avg TTM	9.19
Ev/Sales Ratio Avg 3Y	10.56
Current VS TTM Avg	+1368.84%
Current VS 3Y Avg	+1178.97%
Current VS 5Y Avg	+99.45%

Current Ratio	10.37
Current Ratio Avg TTM	7.21
Current Ratio Avg 3Y	7.34
Current VS TTM Avg	+43.82%
Current VS 3Y Avg	+41.21%
Current VS 5Y Avg	+27.34%

Quick Ratio	10.37
Quick Ratio Avg TTM	7.21
Quick Ratio Avg 3Y	7.34
Current VS TTM Avg	+43.82%
Current VS 3Y Avg	+41.21%
Current VS 5Y Avg	+27.34%

ROIC	(35.90%)
ROIC Avg 3Y	(31.33%)
ROIC Avg 5Y	(26.98%)
Current VS 3Y Avg	-14.59%
Current VS 5Y Avg	-33.08%
Current VS 10Y Avg	-41.76%

ROA	(30.39%)
ROA Avg TTM	(2.17%)
ROA Avg 3Y	(9.24%)
Current VS TTM Avg	-1302.00%
Current VS 3Y Avg	-228.73%
Current VS 5Y Avg	-239.48%

ROE	(33.97%)
ROE Avg TTM	(21.62%)
ROE Avg 3Y	(41.23%)
Current VS TTM Avg	-57.15%
Current VS 3Y Avg	+17.61%
Current VS 5Y Avg	-3.64%

Net Profit Margin	(910.14%)
Net Profit Margin Avg TTM	(1184.23%)
Net Profit Margin Avg 3Y	(960.62%)
Current VS TTM Avg	+23.15%
Current VS 3Y Avg	+5.25%
Current VS 5Y Avg	+6.15%

Gross Profit Margin	100.00%
Gross Pft Margin Avg TTM	100.00%
Gross Pft Margin Avg 3Y	100.00%
Current VS TTM Avg	0.00%
Current VS 3Y Avg	0.00%
Current VS 5Y Avg	+166.56%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A